Reaction
Endocarditis Bacterial reporting signals
As of the last recalculation, Endocarditis Bacterial appears in 779 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is GENTAMICIN (PRR 57.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Gentamicin | 27 | 57.1 | 57.2 |
| Gentamicin Sulfate | 28 | 49.1 | 49.2 |
| Daptomycin | 10 | 29.3 | 29.4 |
| Rifampicin | 10 | 26.7 | 26.8 |
| Basiliximab | 11 | 25.3 | 25.4 |
| Paricalcitol | 13 | 25.0 | 25.0 |
| Ceftriaxone | 28 | 23.6 | 23.6 |
| Obinutuzumab | 14 | 23.1 | 23.2 |
| Ceftriaxone Sodium | 29 | 20.9 | 21.0 |
| Azacitidine For | 14 | 20.9 | 20.9 |
| Melphalan | 16 | 19.2 | 19.2 |
| Micafungin Sodium | 6 | 19.0 | 19.1 |
| Ganciclovir Sodium | 7 | 17.8 | 17.8 |
| Melphalan Hydrochloride | 16 | 17.4 | 17.4 |
| Vancomycin Hydrochloride | 40 | 17.0 | 17.0 |
| Vancomycin | 34 | 16.4 | 16.4 |
| Everolimus Tablets | 10 | 16.1 | 16.1 |
| Thalidomide | 20 | 14.9 | 14.9 |
| Azacitidine | 15 | 13.8 | 13.8 |
| Linezolid | 15 | 13.7 | 13.7 |
| Daratumumab | 17 | 11.6 | 11.6 |
| Remdesivir | 4 | 8.1 | 8.1 |
| Sarilumab | 6 | 6.1 | 6.1 |